Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review

Sang Hun Kim, Nicoleta Stoicea, Suren Soghomonyan, Sergio D Bergese, Sang Hun Kim, Nicoleta Stoicea, Suren Soghomonyan, Sergio D Bergese

Abstract

Introduction: The use of opioids has been increasing in operating room and intensive care unit to provide perioperative analgesia as well as stable hemodynamics. However, many authors have suggested that the use of opioids is associated with the expression of acute opioid tolerance (AOT) and opioid-induced hyperalgesia (OIH) in experimental studies and clinical observations in dose and/or time dependent exposure even when used within the clinically accepted doses. Recently, remifentanil has been used for pain management during anesthesia as well as in the intensive care units because of its rapid onset and offset.

Objectives: Search of the available literature to assess remifentanil AOT and OIH based on available published data.

Methods: We reviewed articles analyzing remifentanil AOT and OIH, and focused our literature search on evidence based information. Experimental and clinical studies were identified using electronic searches of Medline (PubMed, Ovid, Springer, and Elsevier, ClinicalKey).

Results: Our results showed that the development of remifentanil AOT and OIH is a clinically significant phenomenon requiring further research.

Discussions and conclusions: AOT - defined as an increase in the required opioid dose to maintain adequate analgesia, and OIH - defined as decreased pain threshold after chronic opioid treatment, should be suspected with any unexplained pain report unassociated with the disease progression. The clinical significance of these findings was evaluated taking into account multiple methodological issues including the dose and duration of opioids administration, the different infusion mode, the co-administrated anesthetic drug's effect, method assessing pain sensitivity, and the repetitive and potentially tissue damaging nature of the stimuli used to determine the threshold during opioid infusion. Future studies need to investigate the contribution of remifentanil induced hyperalgesia to chronic pain and the role of pharmacological modulation to reverse this process.

Keywords: intraoperative; opioid tolerance; opioid-induced hyperalgesia; postoperative; remifentanil.

References

    1. Aguado D., Abreu M., Benito J., Garcia-Fernandez J, Gomez De Segura I. A. (2011). Ketamine and remifentanil interactions on the sevoflurane minimum alveolar concentration and acute opioid tolerance in the rat. Anesth. Analg. 113 505–512 10.1213/ANE.0b013e318227517a
    1. Angst M. S., Chu L. F., Tingle M. S., Shafer S. L., Clark J. D., Drover D. R. (2009). No evidence for the development of acute tolerance to analgesic, respiratory depressant and sedative opioid effects in humans. Pain 142 17–26 10.1016/j.pain.2008.11.001
    1. Angst M. S., Clark J. D. (2006). Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104 570–587 10.1097/00000542-200603000-00025
    1. Angst M. S., Koppert W., Pahl I., Clark D. J., Schmelz M. (2003). Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 106 49–57 10.1016/S0304-3959(03)00276-8
    1. Benito J., Aguado D., Abreu M. B., Garcia-Fernandez J, Gomez De Segura I. A. (2010). Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat. Br. J. Anaesth. 105 810–817 10.1093/bja/aeq241
    1. Bowdle T. A., Camporesi E. M., Maysick L., Hogue C. W., Jr., Miguel R. V., Pitts M., et al. (1996). A multicenter evaluation of remifentanil for early postoperative analgesia. Anesth. Analg. 83 1292–1297 10.1097/00000539-199612000-00028
    1. Bowdle T. A., Ready L. B., Kharasch E. D., Nichols W. W., Cox K. (1997). Transition to post-operative epidural or patient-controlled intravenous analgesia following total intravenous anaesthesia with remifentanil and propofol for abdominal surgery. Eur. J. Anaesthesiol. 14 374–379 10.1097/00003643-199707000-00006
    1. Burkle H., Dunbar S, Van Aken H. (1996). Remifentanil: a novel, short-acting, mu-opioid. Anesth. Analg. 83 646–651 10.1097/00000539-199609000-00038
    1. Cabanero D., Campillo A., Celerier E., Romero A., Puig M. M. (2009). Pronociceptive effects of remifentanil in a mouse model of postsurgical pain: effect of a second surgery. Anesthesiology 111 1334–1345 10.1097/ALN.0b013e3181bfab61
    1. Celerier E., Rivat C., Jun Y., Laulin J. P., Larcher A., Reynier P., et al. (2000). Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92 465–472 10.1097/00000542-200002000-00029
    1. Chia Y. Y., Liu K., Wang J. J., Kuo M. C., Ho S. T. (1999). Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can. J. Anaesth. 46 872–877 10.1007/BF03012978
    1. Chu L. F., Angst M. S., Clark D. (2008). Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin. J. Pain 24 479–496 10.1097/AJP.0b013e31816b2f43
    1. Compton P., Athanasos P., Elashoff D. (2003). Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study. J. Pain 4 511–519 10.1016/j.jpain.2003.08.003
    1. Compton P., Miotto K., Elashoff D. (2004). Precipitated opioid withdrawal across acute physical dependence induction methods. Pharmacol. Biochem. Behav. 77 263–268 10.1016/j.pbb.2003.10.017
    1. Cooper D. W., Lindsay S. L., Ryall D. M., Kokri M. S., Eldabe S. S., Lear G. A. (1997). Does intrathecal fentanyl produce acute cross-tolerance to i.v. morphine? Br. J. Anaesth. 78 311–313. 10.1093/bja/78.3.311
    1. Cortinez L. I., Brandes V., Munoz H. R., Guerrero M. E., Mur M. (2001). No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br. J. Anaesth. 87 866–869 10.1093/bja/87.6.866
    1. Crawford M. W., Hickey C., Zaarour C., Howard A., Naser B. (2006). Development of acute opioid tolerance during infusion of remifentanil for pediatric scoliosis surgery. Anesth. Analg. 102 1662–1667 10.1213/01.ane.0000216036.95705.c2
    1. De Castro V., Godet G., Mencia G., Raux M., Coriat P. (2003). Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesth. Analg. 96 33–38 10.1097/00000539-200301000-00008
    1. Derrode N., Lebrun F., Levron J. C., Chauvin M., Debaene B. (2003). Influence of peroperative opioid on postoperative pain after major abdominal surgery: sufentanil TCI versus remifentanil TCI. A randomized, controlled study. Br. J. Anaesth. 91 842–849 10.1093/bja/aeg263
    1. Dolin S. J., Cashman J. N., Bland J. M. (2002). Effectiveness of acute postoperative pain management: I. Evidence from published data. Br. J. Anaesth. 89 409–423 10.1093/bja/89.3.409
    1. Echevarria G., Elgueta F., Fierro C., Bugedo D., Faba G., Iniguez-Cuadra R., et al. (2011). Nitrous oxide (N(2)O) reduces postoperative opioid-induced hyperalgesia after remifentanil-propofol anaesthesia in humans. Br. J. Anaesth. 107 959–965 10.1093/bja/aer323
    1. Egan T. D., Lemmens H. J., Fiset P., Hermann D. J., Muir K. T., Stanski D. R., et al. (1993). The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 79 881–892 10.1097/00000542-199311000-00004
    1. Fishbain D. A., Cole B., Lewis J. E., Gao J., Rosomoff R. S. (2009). Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med. 10 829–839 10.1111/j.1526-4637.2009.00653.x
    1. Fodale V., Pratico C., Tescione M., Tanania S., Lucanto T., Santamaria L. B. (2006). Evidence of acute tolerance to remifentanil in intensive care but not in anesthesia. J. Clin. Anesth. 18 293–296 10.1016/j.jclinane.2005.08.015
    1. Glass P. S., Gan T. J., Howell S. (1999). A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth. Analg. 89 S7–S14 10.1097/00000539-199910001-00003
    1. Glass P. S., Hardman D., Kamiyama Y., Quill T. J., Marton G., Donn K. H., et al. (1993). Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth. Analg. 77 1031–1040 10.1213/00000539-199311000-00028
    1. Gomez de Segura I. A., De La Vibora J. B., Aguado D. (2009). Opioid tolerance blunts the reduction in the sevoflurane minimum alveolar concentration produced by remifentanil in the rat. Anesthesiology 110 1133–1138 10.1097/ALN.0b013e31819dadaf
    1. Gu X., Wu X., Liu Y., Cui S., Ma Z. (2009). Tyrosine phosphorylation of the N-Methyl-D-Aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine. Mol. Pain 5 76 10.1186/1744-8069-5-76
    1. Guignard B., Bossard A. E., Coste C., Sessler D. I., Lebrault C., Alfonsi P., et al. (2000). Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93 409–417 10.1097/00000542-200008000-00019
    1. Guignard B., Coste C., Costes H., Sessler D. I., Lebrault C., Morris W., et al. (2002). Supplementing desflurane-remifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements. Anesth. Analg. 95 103–108 10.1097/00000539-200207000-00018
    1. Gustorff B., Nahlik G., Hoerauf K. H., Kress H. G. (2002). The absence of acute tolerance during remifentanil infusion in volunteers. Anesth. Analg. 94 1223–1228 10.1097/00000539-200205000-00032
    1. Hall A. P., Thompson J. P., Leslie N. A., Fox A. J., Kumar N., Rowbotham D. J. (2000). Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation. Br. J. Anaesth. 84 100–102 10.1093/oxfordjournals.bja.a013362
    1. Hansen E. G., Duedahl T. H., Romsing J., Hilsted K. L., Dahl J. B. (2005). Intra-operative remifentanil might influence pain levels in the immediate post-operative period after major abdominal surgery. Acta Anaesthesiol. Scand. 49 1464–1470 10.1111/j.1399-6576.2005.00861.x
    1. Hayashida M., Fukunaga A., Hanaoka K. (2003). Detection of acute tolerance to the analgesic and nonanalgesic effects of remifentanil infusion in a rabbit model. Anesth. Analg. 97 1347–1352 10.1213/01.ANE.0000083370.80416.38
    1. Hood D. D., Curry R., Eisenach J. C. (2003). Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth. Analg. 97 810–815 10.1213/01.ANE.0000078811.80093.88
    1. Hughes M. A., Glass P. S., Jacobs J. R. (1992). Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 76 334–341 10.1097/00000542-199203000-00003
    1. Ishida R., Nikai T., Hashimoto T., Tsumori T., Saito Y. (2012). Intravenous infusion of remifentanil induces transient withdrawal hyperalgesia depending on administration duration in rats. Anesth. Analg. 114 224–229 10.1213/ANE.0b013e318237f678
    1. Ishii H., Petrenko A. B., Kohno T., Baba H. (2013). No evidence for the development of acute analgesic tolerance during and hyperalgesia after prolonged remifentanil administration in mice. Mol. Pain 9 11 10.1186/1744-8069-9-11
    1. Joly V., Richebe P., Guignard B., Fletcher D., Maurette P., Sessler D. I., et al. (2005). Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 103 147–155 10.1097/00000542-200507000-00022
    1. Kapila A., Glass P. S., Jacobs J. R., Muir K. T., Hermann D. J., Shiraishi M., et al. (1995). Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 83 968–975 10.1097/00000542-199511000-00009
    1. Kingston S., Mao L., Yang L., Arora A., Fibuch E. E., Wang J. Q. (2006). Propofol inhibits phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in neurons. Anesthesiology 104 763–769 10.1097/00000542-200604000-00021
    1. Kissin I., Bright C. A., Bradley E. L., Jr. (2000). The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth. Analg. 91 1483–1488 10.1097/00000539-200012000-00035
    1. Koppert W., Angst M., Alsheimer M., Sittl R., Albrecht S., Schuttler J., et al. (2003a). Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans. Pain 106 91–99 10.1016/S0304-3959(03)00294-X
    1. Koppert W., Sittl R., Scheuber K., Alsheimer M., Schmelz M., Schuttler J. (2003b). Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans. Anesthesiology 99 152–159 10.1097/00000542-200307000-00025
    1. Koppert W., Schmelz M. (2007). The impact of opioid-induced hyperalgesia for postoperative pain. Best Pract. Res. Clin. Anaesthesiol. 21 65–83 10.1016/j.bpa.2006.12.004
    1. Lahtinen P., Kokki H., Hynynen M. (2008). Remifentanil infusion does not induce opioid tolerance after cardiac surgery. J. Cardiothorac. Vasc. Anesth. 22 225–229 10.1053/j.jvca.2007.07.004
    1. Laulin J. P., Celerier E., Larcher A., Le Moal M., Simonnet G. (1999). Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity. Neuroscience 89 631–636 10.1016/S0306-4522(98)00652-6
    1. Laulin J. P., Maurette P., Corcuff J. B., Rivat C., Chauvin M., Simonnet G. (2002). The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth. Analg. 94 1263–1269 10.1097/00000539-200205000-00040
    1. Lee L. H., Irwin M. G., Lui S. K. (2005). Intraoperative remifentanil infusion does not increase postoperative opioid consumption compared with 70% nitrous oxide. Anesthesiology 102 398–402 10.1097/00000542-200502000-00024
    1. Li X., Angst M. S., Clark J. D. (2001). Opioid-induced hyperalgesia and incisional pain. Anesth. Analg. 93 204–209 10.1097/00000539-200107000-00040
    1. Luginbuhl M., Gerber A., Schnider T. W., Petersen-Felix S., Arendt-Nielsen L., Curatolo M. (2003). Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth. Analg. 96 726–732 10.1213/01.ANE.0000048086.58161.18
    1. Ma J. F., Huang Z. L., Li J., Hu S. J., Lian Q. Q. (2011). Cohort study of remifentanil-induced hyperalgesia in postoperative patients. Zhonghua Yi Xue Za Zhi 91 977–979
    1. Mao J. (2002). Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 100 213–217 10.1016/S0304-3959(02)00422-0
    1. Martinez V., Fletcher D. (2012). Prevention of opioid-induced hyperalgesia in surgical patients: does it really matter? Br. J. Anaesth. 109 302–304 10.1093/bja/aes278
    1. McAtamney D., O’Hare R., Hughes D., Carabine U., Mirakhur R. (1998). Evaluation of remifentanil for control of haemodynamic response to tracheal intubation. Anaesthesia 53 1223–1227 10.1046/j.1365-2044.1998.00601.x
    1. Minto C. F., Schnider T. W., Egan T. D., Youngs E., Lemmens H. J., Gambus P. L., et al. (1997). Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 86 10–23 10.1097/00000542-199701000-00004
    1. O’Hare R., Mcatamney D., Mirakhur R. K., Hughes D., Carabine U. (1999). Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia. Br. J. Anaesth. 82 283–285 10.1093/bja/82.2.283
    1. Orser B. A., Bertlik M., Wang L. Y., Macdonald J. F. (1995). Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br. J. Pharmacol. 116 1761–1768 10.1111/j.1476-5381.1995.tb16660.x
    1. Perkins F. M., Kehlet H. (2000). Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 93 1123–1133 10.1097/00000542-200010000-00038
    1. Petrenko A. B., Ishii H., Kohno T., Baba H. (2012). When similar is not alike: decreased sensory thresholds after intravenous infusion of remifentanil may not be remifentanil-induced hyperalgesia. Anesth. Analg. 115 977 10.1213/ANE.0b013e318263ca5c
    1. Rauf K., Vohra A., Fernandez-Jimenez P., O’Keeffe N., Forrest M. (2005). Remifentanil infusion in association with fentanyl-propofol anaesthesia in patients undergoing cardiac surgery: effects on morphine requirement and postoperative analgesia. Br. J. Anaesth. 95 611–615 10.1093/bja/aei237
    1. Richebe P., Pouquet O., Jelacic S., Mehta S., Calderon J., Picard W., et al. (2011). Target-controlled dosing of remifentanil during cardiac surgery reduces postoperative hyperalgesia. J. Cardiothorac. Vasc. Anesth. 25 917–925 10.1053/j.jvca.2011.03.185
    1. Richebe P., Rivalan B., Rivat C., Laulin J. P., Janvier G., Maurette P., et al. (2009). Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats. Can. J. Anaesth. 56 126–135 10.1007/s12630-008-9023-4
    1. Rivosecchi R. M., Rice M. J., Smithburger P. L., Buckley M. S., Coons J. C., Kane-Gill S. L. (2014). An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia. Expert Opin. Drug Saf. 13 587–603 10.1517/14740338.2014.902931
    1. Rolke R., Baron R., Maier C., Tolle T. R., Treede R. D., Beyer A., et al. (2006). Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123 231–243 10.1016/j.pain.2006.01.041
    1. Schmidt S., Bethge C., Forster M. H., Schafer M. (2007). Enhanced postoperative sensitivity to painful pressure stimulation after intraoperative high dose remifentanil in patients without significant surgical site pain. Clin. J. Pain 23 605–611 10.1097/AJP.0b013e318122d1e4
    1. Schraag S., Checketts M. R., Kenny G. N. (1999). Lack of rapid development of opioid tolerance during alfentanil and remifentanil infusions for postoperative pain. Anesth. Analg. 89 753–757 10.1097/00000539-199909000-00042
    1. Schuttler J., Albrecht S., Breivik H., Osnes S., Prys-Roberts C., Holder K., et al. (1997). A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 52 307–317 10.1111/j.1365-2044.1997.24-az0051.x
    1. Shin S. W., Cho A. R., Lee H. J., Kim H. J., Byeon G. J., Yoon J. W., et al. (2010). Maintenance anaesthetics during remifentanil-based anaesthesia might affect postoperative pain control after breast cancer surgery. Br. J. Anaesth. 105 661–667 10.1093/bja/aeq257
    1. Simonnet G. (2009). Acute tolerance to opioids: methodological, theoretical and clinical implications. Pain 142 3–4 10.1016/j.pain.2009.01.004
    1. Simonnet G., Rivat C. (2003). Opioid-induced hyperalgesia: abnormal or normal pain? Neuroreport 14 1–7 10.1097/01.wnr.0000051540.96524.e7
    1. Singh H., Vichitvejpaisal P., Gaines G. Y., White P. F. (1995). Comparative effects of lidocaine, esmolol, and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. J. Clin. Anesth. 7 5–8 10.1016/0952-8180(94)00013-T
    1. Singler B., Troster A., Manering N., Schuttler J., Koppert W. (2007). Modulation of remifentanil-induced postinfusion hyperalgesia by propofol. Anesth. Analg. 104 1397–1403 10.1213/01.ane.0000261305.22324.f3
    1. Sneyd J. R., Camu F., Doenicke A., Mann C., Holgersen O., Helmers J. H., et al. (2001). Remifentanil and fentanyl during anaesthesia for major abdominal and gynaecological surgery. An open, comparative study of safety and efficacy. Eur. J. Anaesthesiol. 18 605–614 10.1097/00003643-200109000-00008
    1. Solt K., Eger E. I., II, Raines D. E. (2006). Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics. Anesth. Analg. 102 1407–1411 10.1213/01.ane.0000204252.07406.9f
    1. Song J. W., Lee Y. W., Yoon K. B., Park S. J., Shim Y. H. (2011). Magnesium sulfate prevents remifentanil-induced postoperative hyperalgesia in patients undergoing thyroidectomy. Anesth. Analg. 113 390–397 10.1213/ANE.0b013e31821d72bc
    1. Tompkins D. A., Campbell C. M. (2011). Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon? Curr. Pain Headache Rep. 15 129–136 10.1007/s11916-010-0171-1
    1. Treskatsch S., Klambeck M., Mousa S. A., Kopf A., Schäfer M. (2014). Influence of high-dose intraoperative remifentanil with or without amantadine on postoperative pain intensity and morphine consumption in major abdominal surgery patients: a randomised trial. Eur. J. Anaesthesiol. 31 41–49 10.1097/01.EJA.0000434967.0000403790.0e.
    1. Troster A., Sittl R., Singler B., Schmelz M., Schuttler J., Koppert W. (2006). Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans. Anesthesiology 105 1016–1023 10.1097/00000542-200611000-00024
    1. Vanderah T. W., Gardell L. R., Burgess S. E., Ibrahim M., Dogrul A., Zhong C. M., et al. (2000). Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J. Neurosci. 20 7074–7079
    1. Van Elstraete A. C., Sitbon P., Trabold F., Mazoit J. X., Benhamou D. (2005). A single dose of intrathecal morphine in rats induces long-lasting hyperalgesia: the protective effect of prior administration of ketamine. Anesth. Analg. 101 1750–1756 10.1213/01.ANE.0000184136.08194.9B
    1. Vinik H. R., Kissin I. (1998). Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth. Analg. 86 1307–1311
    1. Wang Q. Y., Cao J. L., Zeng Y. M., Dai T. J. (2004). GABAA receptor partially mediated propofol-induced hyperalgesia at superspinal level and analgesia at spinal cord level in rats. Acta Pharmacol. Sin. 25 1619–1625
    1. Westmoreland C. L., Hoke J. F., Sebel P. S., Hug C. C., Jr., Muir K. T. (1993). Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 79 893–903 10.1097/00000542-199311000-00005
    1. Wilder-Smith O. H., Arendt-Nielsen L. (2006). Postoperative hyperalgesia: its clinical importance and relevance. Anesthesiology 104 601–607 10.1097/00000542-200603000-00028
    1. Woolf C. J., Salter M. W. (2000). Neuronal plasticity: increasing the gain in pain. Science 288 1765–1769 10.1126/science.288.5472.1765
    1. Yalcin N., Uzun S. T., Reisli R., Borazan H., Otelcioglu S. (2012). A comparison of ketamine and paracetamol for preventing remifentanil induced hyperalgesia in patients undergoing total abdominal hysterectomy. Int. J. Med. Sci. 9 327–333 10.7150/ijms.4222
    1. Yarmush J., D’Angelo R., Kirkhart B., O’Leary C., Pitts M. C., II, Graf G., et al. (1997). A comparison of remifentanil and morphine sulfate for acute postoper ative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology 87 235–243 10.1097/00000542-199708000-00009
    1. Yeom J. H., Kim K. H., Chon M. S., Byun J., Cho S. Y. (2012). Remifentanil used as adjuvant in general anesthesia for spinal fusion does not exhibit acute opioid tolerance. Korean J. Anesthesiol. 63 103–107 10.4097/kjae.2012.63.2.103
    1. Zarate E., Sa Rego M. M., White P. F., Duffy L., Shearer V. E., Griffin J. D., et al. (1999). Comparison of adenosine and remifentanil infusions as adjuvants to desflurane anesthesia. Anesthesiology 90 956–963 10.1097/00000542-199904000-00005

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다